Skip to content
    Braavos logo

    Braavos

    London, United KingdomFounded 2019
    braavos.uk
    Biotech & Life SciencesAICybersecurityHardware & Semiconductors

    Braavos Investment Advisers is a London-based venture capital firm that focuses on early-stage investments in science and technology sectors, particularly in companies leveraging scientific breakthroughs. Their strategy involves partnering with entrepreneurs to transform cutting-edge research into successful businesses, with an emphasis on areas such as biotechnology, artificial intelligence, renewable energy, and energy efficiency.

    40% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (1 deals in the last 12 months vs 2 prior). Their most common stage is series-a (80% of deals). Average disclosed round size is $40.9M (across 5 rounds with reported amounts).

    Find people at Braavos on Goldilocks AI

    Portfolio

    5

    Fund Size

    $500M

    Top Stage

    Series A

    Last 12 Mo

    1

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    5 investments
    CompanyRoundAmountDate
    WWild BioscienceSeries A$51MOct 2025
    Salience Labs logoSalience LabsSeries A$30MFeb 2025
    PQShield logoPQShieldSeries B$37MJun 2024
    OOxford IonicsSeries A$36.6MJan 2023
    Charm Therapeutics logoCharm TherapeuticsSeries A$50MJun 2022

    Top Co-Investors

    Oxford Science Enterprises4 shared
    F-Prime Capital1 shared
    OrbiMed1 shared
    General Catalyst1 shared
    Khosla Ventures1 shared
    Axial Partners1 shared
    Cambridge Innovation Capital1 shared
    Silicon Catalyst Ventures1 shared
    Addition1 shared
    Chevron Technology Ventures1 shared
    Legal & General1 shared
    Lansdowne Partners1 shared
    Prosus Ventures1 shared
    Torch Capital1 shared
    Arm Holdings1 shared

    Last updated: 18 March 2026